Journal Watch · Frontiers in Immunology · 2026
A tryptophan metabolism-related gene signature predicts prognosis and immune features in cutaneous melanoma.
Moreover, the TMRG-based risk model developed in this study provides complementary prognostic information and a basis for further investigation of metabolism-associated immune regulation in melanoma.
TL;DR
Moreover, the TMRG-based risk model developed in this study provides complementary prognostic information and a basis for further investigation of metabolism-associated immune regulation in melanoma.
Key findings
- The two risk groups also showed apparent differences in the immune microenvironment, including immune cell composition and immune-related gene expression.
- Drug sensitivity analysis suggested that the two groups may respond differently to several chemotherapeutic and targeted drugs. <i>In vitro</i> experiments showed that IDO1 knockdown altered proliferation, migration, apoptosis, mitochondrial function, and tryptophan metabolism in melanoma cells.<h4>Discussion</h4>These findings suggest that tryptophan metabolism is closely linked to immune heterogeneity and clinical outcomes in patients with SKCM.
- Moreover, the TMRG-based risk model developed in this study provides complementary prognostic information and a basis for further investigation of metabolism-associated immune regulation in melanoma.
What they did
Immune features were further studied using bulk RNA sequencing and single-cell RNA sequencing data. In addition, functional experiments were performed in melanoma cell lines after <i>IDO1</i> knockdown.<h4>Results</h4>The expression of TMRGs was widely altered in SKCM and was related to immune cell infiltration, tumor stemness, mutation features, and metabolic pathway activity. A five-gene risk model, comprising HADHA, GOT2, STAT1, CAT, and IDO1, divided patients into high- and low-risk groups with significantly different overall survival rates, and this model remained an independent predictor even after adjustment for clinicopathological factors.
Full abstract (original)
Background: <h4>Introduction</h4>Tryptophan metabolism is known to affect tumor immunity. However, the value of tryptophan metabolism-related genes (TMRGs) in predicting prognosis and reflecting immune status in skin cutaneous melanoma (SKCM) is not yet clear.<h4>Methods</h4>We analyzed transcriptomic and clinical data of 457 patients with SKCM to elucidate the expression patterns of TMRGs and their links with survival and the tumor immune microenvironment. Unsupervised clustering and Cox regression were used to identify prognostic genes and build a TMRG-based risk model, which was then tested in independent cohorts.
What they did: Immune features were further studied using bulk RNA sequencing and single-cell RNA sequencing data. In addition, functional experiments were performed in melanoma cell lines after <i>IDO1</i> knockdown.<h4>Results</h4>The expression of TMRGs was widely altered in SKCM and was related to immune cell infiltration, tumor stemness, mutation features, and metabolic pathway activity. A five-gene risk model, comprising HADHA, GOT2, STAT1, CAT, and IDO1, divided patients into high- and low-risk groups with significantly different overall survival rates, and this model remained an independent predictor even after adjustment for clinicopathological factors.
Results & conclusions: The two risk groups also showed apparent differences in the immune microenvironment, including immune cell composition and immune-related gene expression. Drug sensitivity analysis suggested that the two groups may respond differently to several chemotherapeutic and targeted drugs. <i>In vitro</i> experiments showed that IDO1 knockdown altered proliferation, migration, apoptosis, mitochondrial function, and tryptophan metabolism in melanoma cells.<h4>Discussion</h4>These findings suggest that tryptophan metabolism is closely linked to immune heterogeneity and clinical outcomes in patients with SKCM. Moreover, the TMRG-based risk model developed in this study provides complementary prognostic information and a basis for further investigation of metabolism-associated immune regulation in melanoma.
Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1806319 · PubMed 42238596.
Why it matters for pharma & biotech
- Relevant to Immunology teams tracking Frontiers in Immunology for new targets, mechanisms and biomarkers.
- Because it reports human data, it can inform indication, endpoint and comparator decisions faster than preclinical work.
- For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.
Limitations & what to check in the full text
- This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
- The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.
Frequently asked questions
What did this Frontiers in Immunology study find?
Moreover, the TMRG-based risk model developed in this study provides complementary prognostic information and a basis for further investigation of metabolism-associated immune regulation in melanoma.
What type of study is this?
It is a cohort / observational clinical study, published in Frontiers in Immunology in 2026. Immune features were further studied using bulk RNA sequencing and single-cell RNA sequencing data.
Where can I read the original paper?
The original is at the publisher via DOI 10.3389/fimmu.2026.1806319. PubMed ID: 42238596. BioStudioAI reproduces the abstract for discussion and links to the source.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/a-tryptophan-metabolism-related-gene-signature-predicts-prognosis-and-im-806319/
Reading papers is step one. Analysing the data is the work.
BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.
Open BioStudioAI More guides